Pelthos Therapeutics Inc. PTHS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$10.24M-420% | -$21.66M-1,025% | -$16.24M-858% | -$3.45M-94.6% | -$1.97M+23.2% | ||
| $469K— | $340K— | —— | —— | $0— | ||
| $1.91M+293% | $1.8M+239% | $2.76M+434% | $413.32K-9.9% | $486K+66.1% | ||
| $2.84M— | —— | —— | —— | $0— | ||
| -$156K— | —— | —— | —— | $0— | ||
| $3.16M+347% | —— | $928.52K-54.5% | $2.4M+252% | $707K+677% | ||
| -$1.91M— | $3.47M+768,684% | $2.67M+8,884,647% | $23.64K+118% | $0+100% | ||
| -$241K— | —— | —— | —— | $0— | ||
| -$498K-916% | —— | $1.46M+100% | -$3.96K— | -$49K-122% | ||
| $1.03M— | —— | $679K— | —— | $0— | ||
| $70K— | —— | —— | —— | $0— | ||
| -$163K— | -$93K— | —— | —— | $0— | ||
| $195K+107% | $0-100% | $109-98.9% | $164.89K— | $94K-84.5% | ||
| -$13.13M-1,977% | -$6.25M-833% | -$15.26M-8,487% | -$447.27K+84.9% | -$632K+68.3% | ||
| $194K— | —— | —— | —— | $0— | ||
| —— | $690.25K— | $690.25K— | $690.25K— | $690.25K— | ||
| -$194K— | -$8M— | —— | —— | $0— | ||
| $0-100% | $0-100% | $68K-49.3% | $375K+180% | $250K+86.6% | ||
| $1.81M— | —— | —— | —— | $0— | ||
| $27.52M+10,909% | $18.02M— | $26.69M— | $375K-76.4% | $250K-95.6% | ||
| $14.2M+3,818% | $3.77M— | $14.19M— | -$72.27K— | -$382K-110% | ||
| $691K— | $0— | $250— | $18.75K— | $0— | ||
| $0— | —— | —— | —— | $0— | ||
| $1.08M— | $1.08M— | —— | —— | $0— | ||
| $195K+107% | $0-100% | $109-98.9% | $164.89K— | $94K-84.5% | ||
| $1.03M— | $877K— | $679K— | $0— | $0— | ||
| -$1.2M— | —— | —— | —— | $0— | ||
| $5.2M— | —— | —— | —— | $0— | ||
| $469K— | —— | —— | —— | $0— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| —— | $1.85M— | $1.85M— | $1.85M— | $1.85M— | ||
| -$163K— | -$93K— | —— | —— | $0— | ||
| -$104K— | —— | —— | —— | $0— | ||
| -$498K-916% | —— | $1.46M+100% | -$3.96K— | -$49K-122% | ||
| $70K— | —— | —— | —— | $0— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $1.81M— | —— | —— | —— | $0— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| —— | $211.25K+293% | $211.25K+293% | $211.25K+293% | $211.25K+293% | ||
| —— | $184.25K-45.9% | $184.25K-45.9% | $184.25K-45.9% | $184.25K-45.9% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| -$241K— | —— | —— | —— | $0— | ||
| -$163K— | -$93K— | —— | —— | $0— | ||
| $0-100% | —— | —— | $12.06K— | $27K— | ||
| $234K— | —— | —— | —— | $0— | ||
| $29.34M— | —— | —— | —— | $0— | ||
| —— | $92.25K— | $92.25K— | $92.25K— | $92.25K— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| —— | $13.25K+657% | $13.25K+657% | $13.25K+657% | $13.25K+657% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $1.36M— | —— | —— | —— | $0— | ||
| $0— | —— | —— | —— | $0— | ||
| -$13.32M-2,008% | —— | —— | —— | -$632K+56.4% | ||
| -$13.32M-2,008% | —— | —— | —— | -$632K+56.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pelthos Therapeutics Inc. generate?
- Pelthos Therapeutics Inc. (PTHS) generated -$35.1M in operating cash flow over the trailing twelve months.
- What is Pelthos Therapeutics Inc.'s free cash flow?
- After $194.0K of capital expenditures, Pelthos Therapeutics Inc.'s free cash flow was -$16.8M over the trailing twelve months.
- Where does Pelthos Therapeutics Inc.'s cash flow data come from?
- Every line is extracted from Pelthos Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
